NCT03117517View on ClinicalTrials.gov

Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

August 29, 2017

Study Completion Date

March 7, 2018

Conditions
Polycystic Ovarian Syndrome
Interventions
DRUG

Metformin

Metformin (1000 mg)

DRUG

Metformin, Pioglitazone

Metformin (1000 mg) Pioglitazone (30 mg)

Trial Locations (1)

25000

Mardan Medical Complex, Mardan

All Listed Sponsors
lead

Khyber Medical University Peshawar

OTHER

NCT03117517 - Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome | Biotech Hunter | Biotech Hunter